CLR is more common in MSI tumors and related to the high amount of tumor infiltrating lymphocytes, as tertiary lymphoid structures enhance and sustain the antitumoral immune reaction by providing a local site for the tumor antigen presenting for dendritic cells, which lead to the activation, proliferation, and differentiation of T and B cells [12, 13]. This evidence concerns the gene DCLK3 and neoplasm.